SCHEMBL7183724

SCHEMBL7183724

C=C(C)Oc1ccc(C(=O)/C=C/c2cc(OC(C)C)ccc2OC(C)C)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 2/20 0.54
KDM4E B2RXH2 1/20 0.49
LMNA P02545 1/20 0.49
MAPT P10636 1/20 0.49
ATM Q13315 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
TDP1 Q9NUW8 1/20 0.46
PTPN1 P18031 6/20 0.46
TNFRSF1A P19438 2/20 0.44
CAPN1 P07384 1/20 0.44
GABRA3 P34903 1/20 0.44
GABRA2 P47869 1/20 0.44
GABRB2 P47870 1/20 0.44
CYP1A1 P04798 1/20 0.43
CYP1B1 Q16678 1/20 0.43
PDE4A P27815 1/20 0.42
PDE4B Q07343 1/20 0.42
PDE4C Q08493 1/20 0.42
PDE4D Q08499 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7183730 1.00 ABCG2 (0.54) ABCG2KDM4ELMNAMAPTATM
SCHEMBL7185731 0.91 TNFRSF1A (0.53) ABCG2LMNAMAPTSMN1; SMN2TDP1
SCHEMBL7185736 0.91 TNFRSF1A (0.53) ABCG2LMNAMAPTSMN1; SMN2TDP1
SCHEMBL7191742 0.87 PTPN1 (0.46) ABCG2KDM4ELMNAMAPTATM
SCHEMBL7191738 0.87 PTPN1 (0.46) ABCG2KDM4ELMNAMAPTATM
SCHEMBL7192107 0.85 ABCG2 (0.71) ABCG2KDM4ELMNAMAPTATM
SCHEMBL7192111 0.85 ABCG2 (0.71) ABCG2KDM4ELMNAMAPTATM
SCHEMBL7184135 0.85 PTPN1 (0.53) ABCG2KDM4ELMNAMAPTATM
SCHEMBL7184138 0.85 PTPN1 (0.53) ABCG2KDM4ELMNAMAPTATM
SCHEMBL7806526 0.83 ABCG2 (0.80) ABCG2KDM4ELMNAMAPTATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed